Having rich experience and thorough understanding of the market operations, we are engaged in offering Mentha Piperita. It is semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. This drug inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Mentha Piperita is bactericidal, and acts on both intracellular and extracellular organisms. Clients can avail our drug in different quantity packaging options and at affordable prices.